Legal & General Group Plc - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 2.36 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$10,0000.0%4,5520.0%0.00%
Q4 2020$10,000
-16.7%
4,5520.0%0.00%
Q3 2020$12,000
-40.0%
4,552
-30.4%
0.00%
Q2 2020$20,000
+53.8%
6,540
-4.9%
0.00%
Q1 2020$13,000
-51.9%
6,878
-25.8%
0.00%
Q4 2019$27,000
-3.6%
9,266
+20.9%
0.00%
Q3 2019$28,000
+27.3%
7,666
+43.0%
0.00%
Q2 2019$22,0005,3610.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$271,9250.08%
Geneos Wealth Management Inc. 427,400$897,5400.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$25,2000.02%
Vivaldi Capital Management LP 19,261$40,4480.01%
Beacon Capital Management, LLC 12,605$26,4710.01%
Atria Wealth Solutions, Inc. 263,300$552,9300.01%
Wealthspire Advisors, LLC 183,862$386,1110.01%
BARRETT & COMPANY, INC. 4,984$10,4660.01%
OSAIC HOLDINGS, INC. 1,271,760$2,670,6560.01%
Ameritas Advisory Services, LLC 45,302$94,8560.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders